Vodicka Pavel, Caja Fabian, Vymetalkova Veronika, Prochazka Pavel, Vodickova Ludmila, Schwarzova Lucie, Slyskova Jana, Kumar Rajiv, Schneiderova Michaela
Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague 14220, Czech Republic ; Department of Molecular Genetics, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague, Prague 12800, Czech Republic.
Department of Immunology and Gnotobiology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague 14220, Czech Republic.
Oncol Lett. 2015 Jan;9(1):183-186. doi: 10.3892/ol.2014.2666. Epub 2014 Nov 4.
Mutations in the mutL homolog 1 ( gene are frequent in patients with hereditary non-polyposis colorectal cancer (CRC). The MLH1 gene was screened for mutations in patients with sporadic CRC. The nucleotide sequences for all 19 exons of were analyzed by high resolution melting and sequenced in a group of 104 sporadic CRC patients, and the results were verified in a replication group of 1,095 patients and 1,469 controls. Different melting profiles for exon 2 of the gene were observed in the germline DNA of one patient. Sequencing of the patient's DNA resulted in the identification of a heterozygous C>G variant at c.204, which resulted in an Ile68Met change in the amino acid. A detailed search of the National Center for Biotechnology Information and the 1000 Genomes databases indicated that the detected variant was unique. According to the SIFT and PolyPhen-2 algorithms, the substitution of Ile to Met was predicted to decrease the activity of the MLH1 protein. The newly identified, functional germline variant was not present in any other CRC patient or control. Thus, a novel germline variant in the gene was identified, representing a rare event in sporadic CRC. The occurrence and relevance of this mutation in other types of cancer requires additional investigation.
错配修复基因MutL同源物1(MutL homolog 1,MLH1)基因的突变在遗传性非息肉病性结直肠癌(hereditary non-polyposis colorectal cancer,HNPCC)患者中很常见。本研究对散发性结直肠癌(sporadic CRC)患者的MLH1基因进行了突变筛查。通过高分辨率熔解分析了104例散发性结直肠癌患者的MLH1基因全部19个外显子的核苷酸序列,并进行了测序,结果在1095例患者的复制组和1469例对照中得到验证。在1例患者的种系DNA中观察到MLH1基因第2外显子不同的熔解曲线。对该患者的DNA测序后,在c.204处鉴定出一个杂合的C>G变异,导致氨基酸发生Ile68Met改变。对美国国立生物技术信息中心(National Center for Biotechnology Information,NCBI)和千人基因组数据库(1000 Genomes databases)进行详细检索后发现,检测到的变异是独特的。根据SIFT和PolyPhen-2算法预测,Ile被Met取代会降低MLH1蛋白的活性。新鉴定出的功能性种系变异在其他结直肠癌患者或对照中均未出现。因此,在MLH1基因中鉴定出一种新的种系变异,这在散发性结直肠癌中是一个罕见事件。该突变在其他类型癌症中的发生情况和相关性需要进一步研究。